The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

A breakthrough in cancer treatment may soon change how some of the most aggressive tumors are managed. A small, ...

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

An ASU alum is encouraging others to get more than one opinion after it took her several doctors to find out she had a tumor ...

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

Neobe is tackling one of the biggest challenges in oncology – making existing cancer drugs more effective in treating solid tumors. Despite the numerous biological treatments available, many of these ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Iovance's Amtagvi is the first TIL therapy approved by the U.S. Food and Drug Administration (FDA). Its first approved ...